WHITEHOUSE STATION, N.J., June 25, 2011
In A New Post-hoc Analysis, Significantly More Patients Achieved Blood Sugar Goals With JANUMET
Related articles
- New Data Analysis Supports The Use Of Daxas® (roflumilast) To Further Stabilise Patients Experiencing Frequent COPD Exacerbations
- Data On Mucosal Healing With HUMIRA In Patients With Active Ulcerative Colitis
- Azithromycin Antibiotic Therapy Appears Beneficial In Treatment Of COPD
- 40% Of Advanced Cancer Patients Are Ignored On Their Care Goals
- Positive CHMP Opinion For Mirabegron In Treatment Of Overactive Bladder Symptoms





Comments